Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa
Moderna Inc.( Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, yesterday announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19…
